Analysis of fluoroquinolones in dusts from intensive livestock farming and the co-occurrence of fluoroquinolone-resistant Escherichia coli.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 03 2019
Historique:
received: 18 07 2018
accepted: 12 03 2019
entrez: 28 3 2019
pubmed: 28 3 2019
medline: 2 10 2020
Statut: epublish

Résumé

Fluoroquinolones are important therapeutics in human and veterinary medicine. This study aimed to retrospectively analyse sedimentation dusts from intensive-livestock-farming barns for fluoroquinolones and investigate the association between resistant Escherichia coli and the detected drugs. Sedimentation-dust samples (n = 125) collected (1980-2009) at 14 barns of unknown-treatment status were analysed by HPLC and tandem-mass spectroscopy to detect enrofloxacin, ciprofloxacin, marbofloxacin, and difloxacin. Recent microbiological data were included to investigate the relationship between fluoroquinolone presence and fluoroquinolone-resistant E. coli. Fifty-nine dust samples (47%) from seven barns contained fluoroquinolone residues. Up to three different fluoroquinolones were detected in pig and broiler barns. Fluoroquinolone concentrations ranged from 10-pg/mg to 46-ng/mg dust. Fluoroquinolone-resistant E. coli were isolated from four barns. Of all the dust samples, 22% contained non-susceptible isolates. Non-susceptible isolate presence in the dust was significantly associated (p = 0.0283) with detecting the drugs, while drug detection increased the odds (4-fold) of finding non-susceptible E. coli (odds ratio = 3.9877, 95% CI: 1.2854-12.3712). This retrospective study shows that fluoroquinolone usage leads to dust contamination. We conclude that farmers and animals inhale/swallow fluoroquinolones and fluoroquinolone-resistant bacteria due to drug application. Furthermore, uncontrolled drug emissions via air exhausted from the barns can be assumed.

Identifiants

pubmed: 30914675
doi: 10.1038/s41598-019-41528-z
pii: 10.1038/s41598-019-41528-z
pmc: PMC6435704
doi:

Substances chimiques

Dust 0
Fluoroquinolones 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5117

Références

Environ Toxicol Pharmacol. 2014 Nov;38(3):792-9
pubmed: 25305740
J Antimicrob Chemother. 1991 Feb;27(2):199-208
pubmed: 2055811
BMC Vet Res. 2016 Apr 01;12:68
pubmed: 27036103
J Appl Microbiol. 2008 Nov;105(5):1421-31
pubmed: 18778293
Vet Rec. 2007 Sep 15;161(11):371-5
pubmed: 17873266
Vet Microbiol. 2007 Sep 20;124(1-2):73-81
pubmed: 17498893
Front Microbiol. 2016 Jun 10;7:866
pubmed: 27375587
J Vet Med Sci. 2016 Mar;78(3):397-403
pubmed: 26596287
Vet Rec. 2000 Jan 15;146(3):76-8
pubmed: 10674696
J Vet Pharmacol Ther. 1999 Jun;22(3):209-12
pubmed: 10447832
Environ Toxicol Pharmacol. 2008 Nov;26(3):272-7
pubmed: 21791374
Interdiscip Perspect Infect Dis. 2012;2012:976273
pubmed: 23097666
Int J Antimicrob Agents. 2005 May;25(5):358-73
pubmed: 15848289
Int J Hyg Environ Health. 2010 Nov;213(6):444-9
pubmed: 20971680
Front Microbiol. 2013 May 23;4:135
pubmed: 23734150
J Antimicrob Chemother. 2001 Jun;47(6):763-71
pubmed: 11389108
Vet Microbiol. 2001 Jul 3;81(1):79-84
pubmed: 11356321
Sci Total Environ. 2014 Jun 1;482-483:269-75
pubmed: 24657372
Clin Microbiol Rev. 2011 Oct;24(4):718-33
pubmed: 21976606
Environ Microbiol Rep. 2013 Feb;5(1):58-65
pubmed: 23757131
Vet Res Commun. 2005 Mar;29 Suppl 1:125-50
pubmed: 15943072
Emerg Infect Dis. 2001 Jan-Feb;7(1):24-34
pubmed: 11266291
Environ Health Perspect. 2003 Oct;111(13):1590-4
pubmed: 14527837
Eur J Med Res. 2005 Apr 20;10(4):145-8
pubmed: 15946909
Vet Res. 2001 May-Aug;32(3-4):275-84
pubmed: 11432418
Porcine Health Manag. 2018 Jun 22;4:13
pubmed: 29977591
Appl Microbiol Biotechnol. 2018 Oct;102(19):8573-8584
pubmed: 30030566
Rev Environ Contam Toxicol. 2007;191:131-62
pubmed: 17708074
J Vet Med Sci. 2014 Sep;76(9):1213-8
pubmed: 24919413
PLoS Pathog. 2011 Jul;7(7):e1002158
pubmed: 21811410
Appl Environ Microbiol. 2012 Aug;78(16):5666-71
pubmed: 22685139
Berl Munch Tierarztl Wochenschr. 2014 Nov-Dec;127(11-12):478-85
pubmed: 25872257
Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H424-33
pubmed: 16155106
Poult Sci. 1998 Nov;77(11):1704-10
pubmed: 9835347
Environ Health Perspect. 2015 Apr;123(4):337-43
pubmed: 25633846

Auteurs

Jochen Schulz (J)

Institute for Animal Hygiene, Animal Welfare and Farm Animal Behaviour, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany. Jochen.schulz@tiho-hannover.de.

Nicole Kemper (N)

Institute for Animal Hygiene, Animal Welfare and Farm Animal Behaviour, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany.

Joerg Hartung (J)

Institute for Animal Hygiene, Animal Welfare and Farm Animal Behaviour, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany.

Franziska Janusch (F)

Institute of Food Chemistry and Food Biotechnology, Justus Liebig University Giessen, Giessen, Germany.
Eurofins WEJ Contaminants GmbH, Hamburg, Germany.

Siegrun A I Mohring (SAI)

Institute of Food Chemistry and Food Biotechnology, Justus Liebig University Giessen, Giessen, Germany.
Thermo Fisher Scientific GmbH, Bremen, Germany.

Gerd Hamscher (G)

Institute of Food Chemistry and Food Biotechnology, Justus Liebig University Giessen, Giessen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH